Literature DB >> 31513912

Zwitterion-functionalized dendrimer-entrapped gold nanoparticles for serum-enhanced gene delivery to inhibit cancer cell metastasis.

Zhijuan Xiong1, Carla S Alves2, Jianhua Wang3, Aijun Li1, Jinyuan Liu1, Mingwu Shen1, João Rodrigues2, Helena Tomás2, Xiangyang Shi4.   

Abstract

We demonstrate a novel serum-enhanced gene delivery approach using zwitterion-functionalized dendrimer-entrapped gold nanoparticles (Au DENPs) as a non-viral vector for inhibition of cancer cell metastasis in vitro. Poly(amidoamine) dendrimers of generation 5 decorated with zwitterion carboxybetaine acrylamide (CBAA) and lysosome-targeting agent morpholine (Mor) were utilized to entrap gold NPs. We show that both Mor-modified and Mor-free Au DENPs are cytocompatible and can effectively deliver plasmid DNA encoding different reporter genes to cancer cells in medium with or without serum. Strikingly, due to the antifouling property exerted by the attached zwitterion CBAA, the gene delivery efficiency of Mor-modified Au DENPs and the Mor-free Au DENPs in the serum-containing medium are 1.4 and 1.7 times higher than the corresponding vector in serum-free medium, respectively. In addition, the Mor-free vector has a better gene expression efficiency than the Mor-modified one although the Mor modification enables the polyplexes to have enhanced cancer cell uptake. Wound healing and hypermethylated in cancer 1 (HIC1) protein expression assay data reveal that the expression of HIC1 gene in cancer cells enables effective inhibition of cell migration. Our findings suggest that the created zwitterion-functionalized Au DENPs may be employed as a powerful vector for serum-enhanced gene therapy of different diseases. STATEMENT OF SIGNIFICANCE: One major challenge in the non-viral gene delivery system is that the strong interaction between serum protein and the positively charged vector/gene polyplexes neutralize the positive charge of the polyplexes and form possible protein corona, thereby significantly reducing their cellular uptake efficiency and subsequent gene transfection outcome. Here we demonstrate the conceptual advances in the serum-enhanced gene delivery using zwitterionic modification of polycationic poly(amidoamine) (PAMAM) dendrimer-entrapped gold nanoparticles (Au DENPs). We demonstrate that partial zwitterionic modification of Au DENPs is able to confer them with antifouling property to resist serum protein adsorption. Hence the vector/DNA polyplexes are able to maintain their positive potentials and small hydrodynamic size in the serum environment, where serum solely play the role as a nutrition factor for enhanced gene delivery. We demonstrate that partial modification of zwitterion carboxybetaine acrylamide (CBAA) and morpholine (Mor) onto the surface Au DENPs renders the vector with both antifouling property and lysosome targeting ability, respectively. The generated functional Au DENPs can compact pDNA to form polyplexes that enable serum-enhanced gene expression. In particular, once complexed with hypermethylated in cancer 1 (HIC1) gene, the polyplexes can significantly inhibit cancer cell migration and metastasis.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dendrimers; Gene delivery; Gold nanoparticles; HIC1 gene; Zwitterions

Mesh:

Substances:

Year:  2019        PMID: 31513912     DOI: 10.1016/j.actbio.2019.09.005

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  9 in total

1.  Characterization of zwitterion-modified poly(amidoamine) dendrimers in aqueous solution via a thorough NMR investigation.

Authors:  Jinyuan Liu; Zhijuan Xiong; Mingwu Shen; Istvan Banyai; Xiangyang Shi
Journal:  Eur Phys J E Soft Matter       Date:  2020-02-04       Impact factor: 1.890

Review 2.  Delivery technologies for in utero gene therapy.

Authors:  Rohan Palanki; William H Peranteau; Michael J Mitchell
Journal:  Adv Drug Deliv Rev       Date:  2020-11-09       Impact factor: 15.470

Review 3.  A review of the tortuous path of nonviral gene delivery and recent progress.

Authors:  Divya Sharma; Sanjay Arora; Jagdish Singh; Buddhadev Layek
Journal:  Int J Biol Macromol       Date:  2021-06-01       Impact factor: 8.025

Review 4.  Hybrid Nanosystems for Biomedical Applications.

Authors:  Joshua Seaberg; Hossein Montazerian; Md Nazir Hossen; Resham Bhattacharya; Ali Khademhosseini; Priyabrata Mukherjee
Journal:  ACS Nano       Date:  2021-01-26       Impact factor: 18.027

5.  Effective CpG Delivery Using Zwitterion-Functionalized Dendrimer-Entrapped Gold Nanoparticles to Promote T Cell-Mediated Immunotherapy of Cancer Cells.

Authors:  Huan Chen; Yiming Zhang; Lulu Li; Rui Guo; Xiangyang Shi; Xueyan Cao
Journal:  Biosensors (Basel)       Date:  2022-01-27

6.  β-Cyclodextrin and Oligoarginine Peptide-Based Dendrimer-Entrapped Gold Nanoparticles for Improving Drug Delivery to the Inner Ear.

Authors:  Jia Luo; XueXin Lin; LiLing Li; JingQian Tan; Peng Li
Journal:  Front Bioeng Biotechnol       Date:  2022-04-11

Review 7.  Development of Polymer-Assisted Nanoparticles and Nanogels for Cancer Therapy: An Update.

Authors:  Bibi Noorheen Haleema Mooneerah Neerooa; Li-Ting Ooi; Kamyar Shameli; Nuraina Anisa Dahlan; Jahid M M Islam; Janarthanan Pushpamalar; Sin-Yeang Teow
Journal:  Gels       Date:  2021-05-17

Review 8.  Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy.

Authors:  Piotr Tarach; Anna Janaszewska
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

Review 9.  Antifouling Strategies of Nanoparticles for Diagnostic and Therapeutic Application: A Systematic Review of the Literature.

Authors:  Paolo Bevilacqua; Silvia Nuzzo; Enza Torino; Gerolama Condorelli; Marco Salvatore; Anna Maria Grimaldi
Journal:  Nanomaterials (Basel)       Date:  2021-03-18       Impact factor: 5.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.